Manufacture

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

We delve into the story behind Lonza’s collaboration with Asahi Kasei Bioprocess America.

How digitalization will revolutionize the way we develop and optimize bioprocesses.

Navigating the cell therapy partnership selection process can be complex. Here, I share the questions you should be asking to help you get it right.

The potential of the cell and gene therapies sector depends – partially – on the expertise of the transport and logistics partners that complement it.

How can companies beat the bottlenecks in viral vector manufacturing?

Is renting material handling equipment the best way to help manufacturers tackle waste?

How Tosoh Biosciences is contributing to a fascinating project on a mission to develop a continuous production process using Escherichia Coli

US-based law and patenting experts offer their thoughts on IP protection in the digital age

Nominations are open now – but only until October 10.